14-day Premium Trial Subscription Try For FreeTry Free
NYSE:CRXM
Delisted

Taxus Cardium Pharmaceuticals Group, Inc Stock Signals

$0.000001
+0 (+0%)
At Close: Nov 10, 2022

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 238 days ( 0 % )
Last Price $0.000001 0 %
High/ Low $0.000001 - $0.000001 0%
Chg 7 Days N/A $0.000001 $0.000001
Chg 30 Days N/A $0.000001 $0.000001
Chg 12 mos -99.00 % $0.0001 $0.000001
Trend - 3 mos N/A Width: 0.00000000 %
Trend - 12 mos -44.55 % Width: 231.37 %
Pred. range - 3 mos $0.000001 - $0.000001 0 % - 0 %
Pred. range - 12 mos N/A - $0.00004171 -100.00 % - 4,070.63 %
Short MA avg 3 mos Sell 0000-00-00 - N/A days
Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short/Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short MA avg 12 mos Sell 2021-12-30 - 219 days
Long MA avg 12 mos Sell 2022-06-15 - 104 days
Short/Long MA avg 12 mos Sell 2022-06-16 - 103 days
Pivot Short Buy 2022-11-09 - 2 days
Bollinger Sell 0000-00-00 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Taxus Cardium Pharmaceuticals Group, Inc

Taxus Cardium Pharmaceuticals Group Gene Biotherapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of angiogenic gene therapy biotherapeutics for the treatment of cardiovascular diseases in the United States. The company's lead product candidate is Generx, an angiogenic gene therapy product candidate in Phase 3 clinical trials for the potential treatment of patients with myocardial ischemia and refractory angina due to advanced ... CRXM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT